Atea Pharmaceuticals, Inc.Atea Pharmaceuticals, Inc.Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

6.200.000.00%
The 1 analyst offering 1 year price forecasts for AVIR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to AVIR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AVIR EPS for the last quarter is −0.37 USD despite the estimation of −0.43 USD. In the next quarter EPS is expected to reach −0.29 USD. Track more of Atea Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Atea Pharmaceuticals, Inc. revenue is expected to reach 0.00 USD. Check out Atea Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, AVIR price target is 6.20 USD with a max estimate of 6.20 USD and a min estimate of 6.20 USD. Check if this forecast comes true in a year, meanwhile watch Atea Pharmaceuticals, Inc. stock price chart and keep track of the current situation with AVIR news and stock market news.